基因名 突变
LYPD3(NM_014400,LY6/PLAUR domain containing 3,346aa) g.19:43965891C>T,c.653G>A,p.G218E
LYPD3(NM_014400,LY6/PLAUR domain containing 3,346aa) g.19:43965844G>A,c.700C>T,p.R234X
LYPD3(NM_014400,LY6/PLAUR domain containing 3,346aa) g.19:43965804G>T,c.740C>A,p.T247K
LYPD3(NM_014400,LY6/PLAUR domain containing 3,346aa) g.19:43965664G>A,c.880C>T,p.P294S
LYPD3(NM_014400,LY6/PLAUR domain containing 3,346aa) g.19:43965594C>T,c.950G>A,p.G317E
LYPD2(NM_205545,LY6/PLAUR domain containing 2,125aa) g.8:143833865C>T,c.5G>A,p.R2Q
LYPD2(NM_205545,LY6/PLAUR domain containing 2,125aa) g.8:143833856C>T,c.14G>A,p.R5Q
LYPD2(NM_205545,LY6/PLAUR domain containing 2,125aa) g.8:143833850G>A,c.20C>T,p.A7V
LYPD2(NM_205545,LY6/PLAUR domain containing 2,125aa) g.8:143832571A>T,c.76T>A,p.Y26N
LYPD2(NM_205545,LY6/PLAUR domain containing 2,125aa) g.8:143831732G>A,c.347C>T,p.T116M
LYPD1(NM_144586,LY6/PLAUR domain containing 1,141aa) g.2:133403668G>A,c.376C>T,p.R126C
LYNX1(NM_177457,Ly6/neurotoxin 1,116aa) g.8:143856736C>T,c.200G>A,p.R67H
LYN(NM_002350,v-yes-1 Yamaguchi sarcoma viral related oncogene homolog,512aa) g.8:56910932C>T,c.1078C>T,p.R360W
LYL1(NM_005583,lymphoblastic leukemia derived sequence 1,280aa) g.19:13211843C>T,c.143G>A,p.R48Q
LYL1(NM_005583,lymphoblastic leukemia derived sequence 1,280aa) g.19:13211736G>A,c.250C>T,p.R84W
LYL1(NM_005583,lymphoblastic leukemia derived sequence 1,280aa) g.19:13211515C>T,c.383G>A,p.R128Q
LYG2(NM_175735,lysozyme G-like 2,212aa) g.2:99861865G>A,c.241C>T,p.Q81X
LYG2(NM_175735,lysozyme G-like 2,212aa) g.2:99860573C>T,c.409G>A,p.G137S
LYG2(NM_175735,lysozyme G-like 2,212aa) g.2:99860537T>C,c.445A>G,p.T149A
LYG2(NM_175735,lysozyme G-like 2,212aa) g.2:99858864A>G,c.602T>C,p.I201T
LYAR(NM_017816,Ly1 antibody reactive,379aa) g.4:4276490C>T,c.436G>A,p.V146I
LYAR(NM_017816,Ly1 antibody reactive,379aa) g.4:4276475C>T,c.451G>A,p.D151N
LYAR(NM_017816,Ly1 antibody reactive,379aa) g.4:4276475C>A,c.451G>T,p.D151Y
LYAR(NM_017816,Ly1 antibody reactive,379aa) g.4:4276317C>A,c.609G>T,p.K203N
LYAR(NM_017816,Ly1 antibody reactive,379aa) g.4:4276198C>T,c.728G>A,p.G243D
LYAR(NM_017816,Ly1 antibody reactive,379aa) g.4:4276132T>C,c.794A>G,p.H265R
LYAR(NM_017816,Ly1 antibody reactive,379aa) g.4:4276124C>A,c.802G>T,p.A268S
LY9(NM_002348,lymphocyte antigen 9,655aa) g.1:160793560A>G,c.1804A>G,p.M602V
注意:这是数据表的摘录,包括在我们的研究中观察到的已发表的多态性位点。 如需完整的变体列表和潜在合作,请联系 huh@cougarlab.org